| Optimized chronomodulated dual release bilayer tablets of fexofenadine and montelukast: quality by design, development, and in vitro evaluation B Singh, G Saini, M Vyas, S Verma, S Thakur Future Journal of Pharmaceutical Sciences 5, 1-20, 2019 | 154 | 2019 |
| Artificial intelligence: the beginning of a new era in pharmacy profession V Mishra Asian Journal of Pharmaceutics (AJP) 12 (02), 2018 | 134 | 2018 |
| An overview of therapeutic effects of vanillic acid N Sharma, N Tiwari, M Vyas, N Khurana, A Muthuraman, P Utreja Plant Arch 20 (2), 3053-3059, 2020 | 101 | 2020 |
| An insight of alpha-amylase inhibitors as a valuable tool in the management of type 2 diabetes mellitus R Bashary, M Vyas, SK Nayak, A Suttee, S Verma, R Narang, GL Khatik Current diabetes reviews 16 (2), 117-136, 2020 | 99 | 2020 |
| Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ... Chemico-biological interactions 304, 10-19, 2019 | 99 | 2019 |
| Recent developments in alpha-glucosidase inhibitors for management of type-2 diabetes: An update B Usman, N Sharma, S Satija, M Mehta, M Vyas, GL Khatik, N Khurana, ... Current pharmaceutical design 25 (23), 2510-2525, 2019 | 82 | 2019 |
| A retrospect study on thiazole derivatives as the potential antidiabetic agents in drug discovery and developments GL Khatik, AK Datusalia, W Ahsan, P Kaur, M Vyas, A Mittal, SK Nayak Current drug discovery technologies 15 (3), 163-177, 2018 | 79 | 2018 |
| Enhanced oral bioavailability and neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson's disease rat model R Kumar, R Kumar, N Khurana, SK Singh, S Khurana, S Verma, ... Food and Chemical Toxicology 144, 111590, 2020 | 67 | 2020 |
| Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases MS Hussain, P Sharma, DS Dhanjal, N Khurana, M Vyas, N Sharma, ... Chemico-biological interactions 348, 109637, 2021 | 48 | 2021 |
| Current strategies and drug targets in the management of type 2 diabetes mellitus P Kaur, A Mittal, SK Nayak, M Vyas, V Mishra, GL Khatik Current drug targets 19 (15), 1738-1766, 2018 | 47 | 2018 |
| TRPC1-mediated Ca2+ entry is essential for the regulation of hypoxia and nutrient depletion-dependent autophagy P Sukumaran, Y Sun, M Vyas, BB Singh Cell death & disease 6 (3), e1674-e1674, 2015 | 47 | 2015 |
| Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis M Mehta, P Prasher, M Sharma, MD Shastri, N Khurana, M Vyas, ... Medical hypotheses 144, 110254, 2020 | 46 | 2020 |
| Vanillin: A comprehensive review of pharmacological activities A Anand, R Khurana, N Wahal, S Mahajan, M Mehta, S Satija, N Sharma, ... Plant Arch 19 (2), 1000-1004, 2019 | 44 | 2019 |
| A review on natural products and herbs used in the management of diabetes D Patle, M Vyas, GL Khatik Current diabetes reviews 17 (2), 186-197, 2021 | 43 | 2021 |
| Potential anti-epileptic phytoconstituents: An updated review J Kaur, P Famta, M Famta, M Mehta, S Satija, N Sharma, M Vyas, ... Journal of ethnopharmacology 268, 113565, 2021 | 39 | 2021 |
| Application of nanotechnology to herbal antioxidants as improved phytomedicine: An expanding horizon Y Mishra, HIM Amin, V Mishra, M Vyas, PK Prabhakar, M Gupta, ... Biomedicine & Pharmacotherapy 153, 113413, 2022 | 38 | 2022 |
| Nutritional profile of spinach and its antioxidant & antidiabetic evaluation M Vyas International Journal of Green Pharmacy (IJGP) 11 (03), 2017 | 38 | 2017 |
| Comparison of antidiabetic and antioxidant activity of wild and cultivated variety of Rauwolfia serpentina S Chauhan, A Kaur, M Vyas, GL Khatik Asian J Pharm Clin Res 10 (12), 404-406, 2017 | 37 | 2017 |
| Hypoxia-inducible factor (HIF): fuel for cancer progression S Satija, H Kaur, MM Tambuwala, P Sharma, M Vyas, N Khurana, ... Current molecular pharmacology 14 (3), 321-332, 2021 | 35 | 2021 |
| Drug delivery approaches for doxorubicin in the management of cancers M Vyas, DA Simbo, M Mursalin, V Mishra, R Bashary, GL Khatik Current Cancer Therapy Reviews 16 (4), 320-331, 2020 | 30 | 2020 |
Dr. Navneet KhuranaProfessor, School of Pharmaceutical Sciences, Lovely Professional University, Jalandharlpu.co.in의 이메일 확인됨
